CIK: 1226675 - Address: C/O Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco, CA 94158
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret111-228191019-268
P%wins0100100100100067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/26/22 18:19
10/25/22
BHVNBiohaven Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDP10010.500105926D
10/5/22 17:39
10/3/22
BHVNBiohaven Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDM.d903.1902816D
12/22/21 21:51
12/20/21
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDM.d28423.630120D
12/22/21 21:51
12/20/21
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDS.d-1,500125.000-12-1000D
11/22/19 21:30
11/22/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDM.d28423.630120D
11/22/19 21:30
11/22/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDS.d-65754.750-12-1000D
2/25/19 16:40
2/21/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDM.d28423.630120D
2/25/19 16:40
2/21/19
BHVNBiohaven Pharmaceutical Holding Co Ltd.D8HealthDrugPharmaceutical PreparationsGregory Julia PCTDS.d-52343.560-12-1000D
3/3/15 21:35
3/2/15
CFRXContrafect CorpDEHealthDrugPharmaceutical PreparationsGregory Julia PNYOCEOP544.610123150D62-5023-228191019-26
1/5/06 17:30
12/30/05
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpS.m-413.770-11-1755B
12/29/04 16:36
12/28/04
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpS-237.600-3-466M
8/12/04 17:14
8/10/04
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpM.d52.5002371D
5/5/04 17:44
5/3/04
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpM.d752.500307769D
5/5/04 17:44
5/3/04
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpS.d-2577.130-36-3469D
1/5/04 17:46
1/2/04
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpM.d502.500203676D
1/5/04 17:46
1/2/04
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpS.d-486.020-8-1076D
12/29/03 14:30
12/26/03
LEXGLexicon Genetics Inc/txDEHealthDiagnIn Vitro & In Vivo DiagnosticGregory Julia PTXOEVP,CorpS-595.920-10-1365D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact